Uscom Limited (UCM.AX)
AUD 0.03
(0.0%)
AUD 0.03
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 3.72 Million AUD | 39.89% |
| 2023 | 2.66 Million AUD | 6.16% |
| 2022 | 2.5 Million AUD | -34.95% |
| 2021 | 3.85 Million AUD | 10.87% |
| 2020 | 3.47 Million AUD | -4.45% |
| 2019 | 3.64 Million AUD | 27.27% |
| 2018 | 2.86 Million AUD | -18.21% |
| 2017 | 3.49 Million AUD | 19.15% |
| 2016 | 2.93 Million AUD | 43.99% |
| 2015 | 2.03 Million AUD | 93.04% |
| 2014 | 1.05 Million AUD | 82.55% |
| 2013 | 578.75 Thousand AUD | -27.12% |
| 2012 | 794.13 Thousand AUD | -5.23% |
| 2011 | 837.99 Thousand AUD | 0.13% |
| 2010 | 836.91 Thousand AUD | -48.67% |
| 2009 | 1.63 Million AUD | 55.02% |
| 2008 | 1.05 Million AUD | 20.71% |
| 2007 | 871.26 Thousand AUD | -22.18% |
| 2006 | 1.11 Million AUD | 133.2% |
| 2005 | 480.1 Thousand AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.7 Million AUD | 0.0% |
| 2024 Q4 | 1.77 Million AUD | 0.0% |
| 2024 FY | 3.72 Million AUD | 39.89% |
| 2023 FY | 2.66 Million AUD | 6.16% |
| 2023 Q4 | 1.64 Million AUD | 0.0% |
| 2023 Q2 | 1.02 Million AUD | 0.0% |
| 2022 Q4 | 1.4 Million AUD | 0.0% |
| 2022 FY | 2.5 Million AUD | -34.95% |
| 2022 Q2 | 1.1 Million AUD | 0.0% |
| 2021 Q2 | 2.26 Million AUD | 0.0% |
| 2021 Q4 | 1.58 Million AUD | 0.0% |
| 2021 FY | 3.85 Million AUD | 10.87% |
| 2020 FY | 3.47 Million AUD | -4.45% |
| 2020 Q4 | 2.79 Million AUD | 0.0% |
| 2020 Q2 | 683.92 Thousand AUD | 0.0% |
| 2019 FY | 3.64 Million AUD | 27.27% |
| 2019 Q4 | 1.78 Million AUD | 0.0% |
| 2019 Q2 | 1.48 Million AUD | 0.0% |
| 2018 Q4 | 1.43 Million AUD | 0.0% |
| 2018 FY | 2.86 Million AUD | -18.21% |
| 2018 Q2 | 1.42 Million AUD | 0.0% |
| 2017 Q2 | 1.9 Million AUD | 0.0% |
| 2017 Q4 | 1.59 Million AUD | 0.0% |
| 2017 FY | 3.49 Million AUD | 19.15% |
| 2016 FY | 2.93 Million AUD | 43.99% |
| 2016 Q4 | 1.45 Million AUD | 0.0% |
| 2016 Q2 | 1.47 Million AUD | 0.0% |
| 2015 FY | 2.03 Million AUD | 93.04% |
| 2015 Q2 | 1.1 Million AUD | 0.0% |
| 2015 Q4 | 932.54 Thousand AUD | 0.0% |
| 2014 Q1 | 144.68 Thousand AUD | -47.47% |
| 2014 FY | 1.05 Million AUD | 82.55% |
| 2014 Q4 | 990.59 Thousand AUD | 275.05% |
| 2014 Q3 | 264.12 Thousand AUD | -31.77% |
| 2014 Q2 | 387.11 Thousand AUD | 167.55% |
| 2013 FY | 578.75 Thousand AUD | -27.12% |
| 2013 Q4 | 275.42 Thousand AUD | 90.36% |
| 2013 Q3 | 144.68 Thousand AUD | 0.0% |
| 2013 Q2 | 144.68 Thousand AUD | -27.12% |
| 2013 Q1 | 198.53 Thousand AUD | 0.0% |
| 2012 Q3 | 198.53 Thousand AUD | 0.0% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 FY | 794.13 Thousand AUD | -5.23% |
| 2012 Q1 | 209.49 Thousand AUD | 0.0% |
| 2012 Q2 | 198.53 Thousand AUD | -5.23% |
| 2011 Q2 | 209.49 Thousand AUD | 0.13% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 FY | 837.99 Thousand AUD | 0.13% |
| 2011 Q1 | 209.22 Thousand AUD | 0.0% |
| 2011 Q3 | 209.49 Thousand AUD | 0.0% |
| 2010 FY | 836.91 Thousand AUD | -48.67% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 209.22 Thousand AUD | 0.0% |
| 2010 Q1 | 407.59 Thousand AUD | 0.0% |
| 2010 Q2 | 209.22 Thousand AUD | -48.67% |
| 2009 Q4 | - AUD | -100.0% |
| 2009 FY | 1.63 Million AUD | 55.02% |
| 2009 Q2 | 407.59 Thousand AUD | 55.02% |
| 2009 Q3 | 407.59 Thousand AUD | 0.0% |
| 2009 Q1 | 262.92 Thousand AUD | 0.0% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 Q3 | 262.92 Thousand AUD | 0.0% |
| 2008 FY | 1.05 Million AUD | 20.71% |
| 2008 Q1 | 217.81 Thousand AUD | 0.0% |
| 2008 Q2 | 262.92 Thousand AUD | 20.71% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 FY | 871.26 Thousand AUD | -22.18% |
| 2007 Q3 | 217.81 Thousand AUD | 0.0% |
| 2007 Q2 | 217.81 Thousand AUD | -22.18% |
| 2007 Q1 | 279.9 Thousand AUD | 0.0% |
| 2006 FY | 1.11 Million AUD | 133.2% |
| 2006 Q2 | 279.9 Thousand AUD | 133.2% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q3 | 279.9 Thousand AUD | 0.0% |
| 2006 Q1 | 120.02 Thousand AUD | 0.0% |
| 2005 FY | 480.1 Thousand AUD | 0.0% |
| 2005 Q2 | 120.02 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 Q3 | 120.02 Thousand AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q2 | - AUD | 0.0% |
| 2003 Q3 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | 0.73% |
| Adherium Limited | 840.98 Thousand AUD | -343.154% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 94.118% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 8.802% |
| Anteris Technologies Ltd | 4.11 Million AUD | 9.346% |
| Control Bionics Limited | 5.12 Million AUD | 27.308% |
| CardieX Limited | 10.9 Million AUD | 65.826% |
| Compumedics Limited | 49.71 Million AUD | 92.504% |
| Cochlear Limited | 2.25 Billion AUD | 99.835% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 76.295% |
| Cyclopharm Limited | 27.13 Million AUD | 86.268% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 66.782% |
| Nova Eye Medical Limited | 23.32 Million AUD | 84.022% |
| HeraMED Limited | 402.89 Thousand AUD | -825.012% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -505.432% |
| ImpediMed Limited | 10.31 Million AUD | 63.884% |
| InhaleRx Limited | 1.2 Million AUD | -209.527% |
| LBT Innovations Limited | 1.25 Million AUD | -196.723% |
| Micro-X Limited | 15.22 Million AUD | 75.517% |
| Neurotech International Limited | 1963.00 AUD | -189754.559% |
| OncoSil Medical Limited | 1.56 Million AUD | -138.079% |
| PolyNovo Limited | 103.19 Million AUD | 96.388% |
| Respiri Limited | 456.91 Thousand AUD | -715.656% |
| SomnoMed Limited | 91.65 Million AUD | 95.934% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 43.812% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 57.014% |